HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
4th Edition of Cardiology World Conference
September 18-20, 2022 | Hybrid Event
Cardiovascular Pharmacology
Cardiovascular Pharmacology
Cardiovascular pharmacology: Cardiovascular pharmacology involves drugs that are used in the treatment of cardiovascular diseases. Many medications are used to treat various heart conditions. Some examples of the drugs used as cardiovascular medicine include:
- Anticoagulants or blood thinners
- Antiplatelet agents
- Thrombolytic agents
- Angiotensin-converting enzyme (ACE) inhibitors
- Angiotensin II receptor blockers (ARBs)
- Diuretics
- Calcium channel blockers
- Vasodilators
- Digoxin
Committee Members
Yochai Birnbaum
Baylor College of Medicine, United States
Sekib Sokolovic
Sarajevo University Clinical Center, Bosnia and Herzegowina
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation Cardio 2023 Speakers
Samuil Ivanovsky
University of Arkansas for Medical Sciences, United States
Jake Kieserman
Hospital of the University of Pennsylvania, United States
Kate Tauber
Albany Medical Center, United States
Indrajeet Mahata
University of Missouri, United StatesSubmit your abstract Today
Title : Should we continue to prescribe aspirin for patients with coronary artery disease?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : A single site experience of implementation of a Gastrostomy Tube (G-Tube) weaning protocol in single ventricle patients
Sarah Watson, Children's Hospital Colorado, United States
Title : Optimizing nutrition for infants with congenital heart disease
Kate Tauber, Albany Medical Center, United States
Title : Effect of extracardial myocardial revascularization on long-term results of surgical treatment of patients with coronary heart disease
Yuriy Leonidovich Shevchenko, Pirogov National Medical and Surgical Center, Russian Federation
Title : Between the brain and the heart: Effects of reward system activation on the recovery process following myocardial infarction
Hedva Haykin, Technion- Institute of Technology, Israel
Title : Targets for the prevention of comorbidity of cardiovascular and oncological diseases
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation